April 16, 2026
FDA Removes 12 Popular Peptides from Category 2: What This Means for Peptide Entrepreneurs
HHS Secretary Robert F. Kennedy Jr. announced a key regulatory change that could open doors for the peptide industry.
Read ArticleRegulatory updates, market analysis, and sourcing insights for the peptide supply chain.
HHS Secretary Robert F. Kennedy Jr. announced a key regulatory change that could open doors for the peptide industry.
Read Article